Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Other Non Operating Income: 2019-2024

Historic Other Non Operating Income for Phathom Pharmaceuticals (PHAT) over the last 6 years, with Dec 2024 value amounting to -$8,000.

  • Phathom Pharmaceuticals' Other Non Operating Income rose 12.50% to -$7,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$135,000, marking a year-over-year decrease of 90.14%. This contributed to the annual value of -$8,000 for FY2024, which is 95.74% up from last year.
  • As of FY2024, Phathom Pharmaceuticals' Other Non Operating Income stood at -$8,000, which was up 95.74% from -$188,000 recorded in FY2023.
  • Phathom Pharmaceuticals' 5-year Other Non Operating Income high stood at -$8,000 for FY2020, and its period low was -$2.1 million during FY2021.
  • Over the past 3 years, Phathom Pharmaceuticals' median Other Non Operating Income value was -$110,000 (recorded in 2022), while the average stood at -$102,000.
  • Per our database at Business Quant, Phathom Pharmaceuticals' Other Non Operating Income tumbled by 25,600.00% in 2021 and then skyrocketed by 95.74% in 2024.
  • Yearly analysis of 5 years shows Phathom Pharmaceuticals' Other Non Operating Income stood at -$8,000 in 2020, then slumped by 25,600.00% to -$2.1 million in 2021, then skyrocketed by 94.65% to -$110,000 in 2022, then tumbled by 70.91% to -$188,000 in 2023, then skyrocketed by 95.74% to -$8,000 in 2024.